Clinical Trial Update: Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing intracoronary rhTNK-tPA (tenecteplase) with tirofiban in patients with ST-segment Elevation Myocardial Infarction and high th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• TNK-tPA (tenecteplase) (tenecteplase)
• tirofiban (tirofiban)

Snippet

Sponsor: Henan Institute of Cardiovascular Epidemiology | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | Phase 4 | Status: RECRUITING